These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 704210

  • 1. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T, Bigley J.
    Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
    [Abstract] [Full Text] [Related]

  • 2. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
    Katz RM, Rachelefsky GS, Siegel SC, Mickey R.
    Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
    [Abstract] [Full Text] [Related]

  • 3. Use of a twelve-hour theophylline preparation in chronic adult asthmatics.
    Tinkelman D, Vanderpool G, Carroll MS, Spangler DL.
    Ann Allergy; 1979 Sep; 43(3):155-9. PubMed ID: 573076
    [Abstract] [Full Text] [Related]

  • 4. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R, Kelly HW, Howick J, McWilliams BC.
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [Abstract] [Full Text] [Related]

  • 5. [Clinical effectiveness of a new preparation of sustained-release theophylline].
    Corrias A, Pelosi U, Corona GB, Burrai P, Corda R.
    Pediatr Med Chir; 1989 May; 11(5):537-9. PubMed ID: 2631061
    [Abstract] [Full Text] [Related]

  • 6. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA, Straughan AB.
    Clin Ther; 1994 May; 16(5):804-14. PubMed ID: 7859239
    [Abstract] [Full Text] [Related]

  • 7. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S, Laver J, Benson L, Cotariu D, Neli P, Saidman JL, Viure E.
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [Abstract] [Full Text] [Related]

  • 8. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG, Miller E, Janky DG, Decouto J, Edelman L.
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [Abstract] [Full Text] [Related]

  • 9. Comparison of two dosage schedules of sustained release theophylline in pediatric patients.
    Loren ML, Kirsten EB.
    Ann Allergy; 1980 Apr; 44(4):200-3. PubMed ID: 7369552
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessing the efficacy and safety of q. d. theophylline therapy: a multicenter study.
    Dockhorn RJ, Green AW, Green E.
    Ann Allergy; 1985 Nov; 55(5):658-64. PubMed ID: 2865917
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels.
    Rachelefsky GS, Katz RM, Siegel SC.
    Ann Allergy; 1978 Apr; 40(4):252-7. PubMed ID: 345889
    [Abstract] [Full Text] [Related]

  • 17. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
    Tinkelman DG, Lutz CN, Miller E, Cole WQ.
    Ann Allergy; 1987 Mar; 58(3):190-2. PubMed ID: 3826771
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
    Iwasaki E, Baba M.
    Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
    [Abstract] [Full Text] [Related]

  • 19. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B, Brannan MD, Groen H, Peeters PA, Hempenius J, Radwanski E, Nomeir AA, Affrime MB, Jonkman JH.
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [Abstract] [Full Text] [Related]

  • 20. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L, Iafrate RP, Weinberger M.
    Clin Pharmacokinet; 1984 Aug; 9(2):95-135. PubMed ID: 6370542
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.